The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

October 2020

Volume 16 Number 8

A mini focus on radiation risk covers two recent trials exploring ways to reduce operator exposure; two articles come out of the GLOBAL LEADERS trial and explore the efficacity of ticagrelor monotherapy: GLASSY is a substudy following the efficacity of ticagrelor monotherapy after one-month DAPT in patients with or without ACS, the other is a post hoc analysis of ticagrelor monotherapy in patients receiving long stents; the COMPARE-ABSORB trial examines the use of coronary scaffolds in patients at high risk for restenosis comparing them with drug-eluting stents; the POLBOS LM trial protocol looks at a dedicated bifurcation stent and, in valvular disease and heart failure, an article reviews and comments on the Leipzig experience with the BASILICA technique.

Highlights from this issue

GLASSY ACS vs SIHD
GLASSY ACS vs SIHD
Franzone A, McFadden E, Leonardi S, Piccolo R, Vranckx P, Serruys P, Hamm C, Steg P, Heg D, Branca M, Jüni P, Windecker S, Valgimigli M
October 23, 2020
DOI: 10.4244/EIJ-D-20-00145
Bioresorbable scaffolds in high-risk patients
Bioresorbable scaffolds in high-risk patients
Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Wlodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R
October 23, 2020
DOI: 10.4244/EIJ-D-19-01079
The Leipzig BASILICA experience
The Leipzig BASILICA experience
Kitamura M, Majunke N, Holzhey D, Desch S, Bani Hani A, Krieghoff C, Gutberlet M, Protsyk V, Ender J, Borger M, Dvir D, Thiele H, Abdel-Wahab M
October 23, 2020
DOI: 10.4244/EIJ-D-20-00386

Coronary interventions